Table I.

Acute patients’ characteristics.

	Phase of disease	Sex	Age at diagnosis (years)	Time from diagnosis (months)	Baseline platelet count (n×109/L)	Overall response	Complete response	Relapse	Duration of response (days)
1	Newly diagnosed	F	7	0.2	3	No	X	X	X
2	Newly diagnosed	M	12.7	0	5	Yes	No	No	X
3	Newly diagnosed	M	1.3	1.1	19	Yes	No	Yes	32
4	Newly diagnosed	M	11	1	17	Yes	Yes	No	X
5	Newly diagnosed	F	3.2	1	11	Yes	No	Yes	46
6	Newly diagnosed	M	5.8	2	3	No	X	X	X
7	Newly diagnosed	F	10.5	0	5	Yes	Yes	No	X
8	Newly diagnosed	M	10	2	8	Yes	No	Yes	28
9	Newly diagnosed	M	0.9	0	14	No	X	X	X
10	Newly diagnosed	F	15.4	1	4	No	X	X	X
11	Newly diagnosed	F	11	2	4	Yes	No	Yes	22
12	Newly diagnosed	F	12	2	6	Yes	No	No	X
13	Persistent	M	5.6	3	13	Yes	Yes	Yes	27
14	Persistent	F	14.6	4	6	No	X	X	X
15	Persistent	F	9	7	3	Yes	No	Yes	14.5
16	Persistent	F	9	6	14	Yes	Yes	Yes	41
17	Persistent	M	5	6	15	Yes	No	Yes	29
18	Persistent	M	12	8	5	Yes	Yes	Yes	13
19	Persistent	F	4	11	7	Yes	Yes	Yes	73
20	Persitent	M	1	5.7	2	No	No	X	X
21	Chronic	F	4.7	19	9	Yes	Yes	Yes	13
22	Chronic	M	5.8	26	4	Yes	Yes	Yes	77.37
23	Chronic	M	6.3	55	8	Yes	Yes	Yes	134
24	Chronic	F	10.5	21	8	Yes	Yes	Yes	65
25	Chronic	F	4.9	38	4	No	X	X	X
26	Chronic	F	8.9	27	19	Yes	Yes	Yes	89
27	Chronic	M	0.6	14	13	Yes	No	Yes	12
28	Chronic	F	1.5	137	22	Yes	No	Yes	19
29	Chronic	M	11	38	6	Yes	No	Yes	11
30	Chronic	F	2	36	0	Yes	Yes	Yes	20.6
31	Chronic	F	11	43	9	Yes	Yes	Yes	116
32	Chronic	M	7	19	7	Yes	Yes	Yes	34
33	Chronic	F	5	14	4	No	No	X	36.5
34	Chronic	M	12	48	7	Yes	Yes	Yes	111

Overall response: platelet count >50×10⁹/L and at least 30×10⁹/L over the baseline count and remission of active bleeding.

Complete response: platelet count >150×10⁹/L.